Web app for reporting side effects during radiation therapy
Programme for Development and Use of a Web-based Application for Monitornig Complications of Radiation Therapy in Cancer Patients and Analysis of Its Effectiveness
This project will try a web app that lets people receiving radiation for breast, gynecologic, or urologic cancers report symptoms and quality of life so clinicians can spot problems earlier.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Institute of Oncology Ljubljana Academic / other |
| Locations | 1 site (Ljubljana) |
| Trial ID | NCT07416630 on ClinicalTrials.gov |
What this trial studies
This prospective project develops and implements a secure web-based application for patients to complete standardized electronic patient-reported outcome questionnaires during and after radiotherapy. Participants will complete weekly questionnaires during treatment and at each scheduled follow-up visit for up to two years, with responses sent via HTTPS to the Institute of Oncology Ljubljana. Responses will be triaged by a traffic-light system to guide clinical actions and prioritize follow-up, aiming to support remote monitoring and optimize clinic workload. Healthcare professionals at the Institute will review submissions and use them to inform timely interventions and reduce unnecessary outpatient visits.
Who should consider this trial
Good fit: Patients receiving radiotherapy for breast, gynecologic, or urologic cancers at the Institute of Oncology Ljubljana who can access and use a smartphone, tablet, or computer and who provide informed consent.
Not a fit: Patients who cannot understand or complete the questionnaires, cannot use an internet-enabled device, or who are treated outside the Institute of Oncology Ljubljana are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, the app could help detect radiotherapy side effects earlier, reduce unnecessary clinic visits, and improve patients' quality of life.
How similar studies have performed: Electronic PROM monitoring has been used in other cancer settings and has shown improved symptom detection and sometimes reduced acute care use, so this builds on established approaches.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients receiving radiotherapy for gynecologic cancer, urologic cancer, or breast cancer at the Institute of Oncology Ljubljana. * Ability to access and use the web-based application on a smartphone, computer, or tablet. * Signed written informed consent. Exclusion Criteria: * Inability to understand the questionnaire questions and provide meaningful answers.
Where this trial is running
Ljubljana
- Institute of Oncology Ljubljana — Ljubljana, Slovenia (Recruiting)
Study contacts
- Study coordinator: Barbara Zobec Logar, MD
- Email: HLogar@onko-i.si
- Phone: +38615879273
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.